ConductScience.org, home

Paper39684602

Replacing 2 Gy Per Fraction Equivalent Dose with Fractionation-Specific Biological Equivalent Dose for Normal Tissues.

Luo W and 1 other. Int J Mol Sci, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Replacing 2 Gy Per Fraction Equivalent Dose with Fractionation-Specific Biological Equivalent Dose for Normal Tissues. Papers, record 39684602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39684602

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Replacing 2 Gy Per Fraction Equivalent Dose with Fractionation-Specific Biological Equivalent Dose for Normal Tissues.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.76, provisional
iCite
Revised in PubMed
2025-01-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Luo WWei
2St Clair WWilliam

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dose Fractionation, RadiationMajor topic
Humans
Relative Biological Effectiveness

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118262098Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.Int J Radiat Oncol Biol Phys2008https://conductscience.org/library/papers/18262098PubMed
215566178Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.Phys Med Biol2004https://conductscience.org/library/papers/15566178PubMed
310078651The assessment of RBE effects using the concept of biologically effective dose.Int J Radiat Oncol Biol Phys1999https://conductscience.org/library/papers/10078651PubMed
412128128Intensity-modulated radiation therapy (IMRT) for meningioma.Int J Radiat Oncol Biol Phys2002https://conductscience.org/library/papers/12128128PubMed
54063711The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.Br J Radiol1985https://conductscience.org/library/papers/4063711PubMed
625212601Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer.J Radiat Res2015https://conductscience.org/library/papers/25212601PubMed
728490978Radiobiology of stereotactic body radiation therapy (SBRT).Rep Pract Oncol Radiother2017https://conductscience.org/library/papers/28490978PubMed
86680223A new isoeffect curve for change in dose per fraction.Radiother Oncol1983https://conductscience.org/library/papers/6680223PubMed
99392533Brainstem tolerance to conformal radiotherapy of skull base tumors.Int J Radiat Oncol Biol Phys1997https://conductscience.org/library/papers/9392533PubMed
1038986531Abscopal Effects, Clastogenic Effects and Bystander Effects: 70 Years of Non-Targeted Effects of Radiation.Radiat Res2024https://conductscience.org/library/papers/38986531PubMed
1122929858Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.Int J Radiat Oncol Biol Phys2013https://conductscience.org/library/papers/22929858PubMed
1233305075Moderately Hypofractionated Radiation for Benign Meningiomas and Schwannomas: A Report of 70 Patients Treated Between 2008 and 2018.Adv Radiat Oncol2020https://conductscience.org/library/papers/33305075PubMed
1316997503
Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
Int J Radiat Oncol Biol Phys2006https://conductscience.org/library/papers/16997503PubMed
142798939Time-dependent tumour repopulation factors in linear-quadratic equations--implications for treatment strategies.Radiother Oncol1989https://conductscience.org/library/papers/2798939PubMed
1517022202Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.Med Phys2006https://conductscience.org/library/papers/17022202PubMed
1618841869Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.Med Phys2008https://conductscience.org/library/papers/18841869PubMed
176759484Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.Int J Radiat Oncol Biol Phys1982https://conductscience.org/library/papers/6759484PubMed
1811373882The role of biologically effective dose (BED) in clinical oncology.Clin Oncol (R Coll Radiol)2001https://conductscience.org/library/papers/11373882PubMed
192380091The incidence of myelitis after irradiation of the cervical spinal cord.Int J Radiat Oncol Biol Phys1990https://conductscience.org/library/papers/2380091PubMed
2018725110The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.Semin Radiat Oncol2008https://conductscience.org/library/papers/18725110PubMed

See all 41 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41736134Consequences of irradiation on blood-brain tumor barrier model of Diffuse Midline Glioma: characterization of physical and metabolic properties.Fluids Barriers CNS2026https://conductscience.org/library/papers/41736134PubMed
40426936A Statistical Approach to Assess Biological Equivalent Mean Organ Dose (MOD) for Different Fractionations in Thoracic Radiotherapy.Biomedicines2025https://conductscience.org/library/papers/40426936PubMed
40156204Dose-Volume Constraints for Thoracic, Abdominal, and Pelvic Carbon Ion Radiotherapy: A Literature Review.Cancer Med2025https://conductscience.org/library/papers/40156204PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39684602

GET https://conductscience.org/api/papers/v1/39684602/references?page=2